Stock OXB OXFORD BIOMEDICA PLC
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Oxford Biomedica plc

Equities

OXB

GB00BDFBVT43

Real-time Estimate Cboe Europe
Other stock markets
 06:11:00 2024-05-08 EDT 		5-day change 1st Jan Change
329.8 GBX +4.35% Intraday chart for Oxford Biomedica plc +14.82% +49.78%
05-03 Jefferies cuts AJ Bell; Deutsche likes ConvaTec AN
04-29 FTSE 100 as investors look to Fed rate decision AN

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
FTSE 100 as investors look to Fed rate decision
AN
Oxford BioMedica bullish; Petrofac slumps
AN
Earnings Flash (OXB.L) OXFORD BIOMEDICA Reports FY23 Revenue GBP89.5M
MT
Oxford Biomedica plc Reiterates Earnings Guidance for the Year 2024
CI
Oxford Biomedica plc Reports Earnings Results for the Full Year Ended December 31, 2023
CI
EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake
AN
Oxford Biomedica Secures New Deal, Expands Existing Agreements for Clinical Programs
MT
EARNINGS AND TRADING: Harland & Wolff wins major Falklands contract
AN
Oxford Biomedica plc Provides Earnings Guidance for the Year Ended December 31, 2023 and for the Fiscal Year 2024
CI
Oxford Biomedica Completes EUR15 Million ABL Europe Acquisition
MT
Institut Merieux ups stake in Oxford BioMedica toward 10%
AN
Oxford Biomedica plc completed the acquisition of additional 3.2% stake in ABL EUROPE S.A.S. from TSGH ?6.1 million
CI
Oxford BioMedica posts optimistic outlook on uptick in contract value
AN
Oxford Biomedica plc Provides Business Update
CI
Oxford Biomedica to Buy ABL Europe from Institut Mérieux
MT
Oxford BioMedica buys ABL Europe for consideration of EUR15 million
AN
Oxford Biomedica plc entered into a sale and purchase agreement to acquire additional 3.2% stake in ABL EUROPE S.A.S. from TSGH.
CI
Oxford Biomedica plc entered into a sale and purchase agreement to acquire ABL EUROPE S.A.S. from TSGH for ?15 million.
CI
Oxford BioMedica shares up, in talks to buy ABL Europe but loss widens
AN
Oxford BioMedica Gains 10% Amid Talks to Acquire ABL Europe
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OXB Stock
  4. News Oxford Biomedica plc
  5. Highlights
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW